Heritability And Genetics Of Lipid Metabolism

Bibliography

• Muoio DM, Newgard CB: Obesity-related derangements in metabolic regulation. Annu. Rev. Biochem. 75, 367–401 (2006).
   Google Scholar
• Outstanding review of the metabolism of obesity. The review covers the very complex metabolic pathways and discusses them in detail.
   Google Scholar
• Fenger M, Schousboe K, Sorensen TI, Kyvik KO: Variance decomposition of apolipoproteins and lipids in Danish twins. Atherosclerosis 191(1), 40–47 (2007).
   Google Scholar
• Thorough investigation of the heritabilities of lipoprotiens in a large twin-study. It discusses the differences in heritabily found between studies, pinpointing the essence of population specific heritability.
   Google Scholar
• Das UN: Essential Fatty acids - a review. Curr. Pharm. Biotechnol. 7(6), 467–482 (2006).
   Google Scholar
• Underscores the importance of essential fatty acids. It puts essential fatty acids in perspective discussing several major diseases in which they are supposedly pivotal for the diseases.
   Google Scholar
• Forrester JS, Milne SB, Ivanova PT, Brown HA: Computational lipidomics: A multiplexed analysis of dynamic changes in membrane lipid composition during signal transduction. Mol. Pharmacol. 65(4), 813–821 (2004).
   Google Scholar
• Kester M, Kolesnick R: Sphingolipids as therapeutics. Pharmacol. Res. 47(5), 365–371 (2003).
   Google Scholar
• Interesting presentation of the delicate balance between ceramide and sphingosine1-phosphate and its impact, particularly in cancer.
   Google Scholar
• Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG: Replication validity of genetic association studies. Nat. Genet. 29(3), 306–309 (2001).
   Google Scholar
• Reviews the unsettling lack of replication of genetic studies searching for single gene effects.
   Google Scholar
• Sevin M, Lesca G, Baumann N, Millat G, Lyon-Caen O, Vanier MT et al.: The adult form of Niemann-Pick disease Type C. Brain 130(1), 120–133 (2007).
   Google Scholar
• Dedoussis GV, Schmidt H, Genschel J: LDL-receptor mutations in Europe. Hum. Mutat. 24(6), 443–459 (2004).
   Google Scholar
• Comprehensive review of the regional distribution of LDL receptor mutations in Europe that discusses strategies for genotyping the huge numbers of mutations.
   Google Scholar
• Giuffrida FM, Reis AF: Genetic and clinical characteristics of maturity-onset diabetes of the young. Diabetes Obes. Metab. 7(4), 318–326 (2005).
   Google Scholar
• Excellent review of the status the genetics of diabetes.
   Google Scholar
• Hayhurst GP, Lee YH, Lambert G et al.: Hepatocyte nuclear factor 4 (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol. Cell Biol. 21(4), 1393–1403 (2001).
   Google Scholar
• Documents the importance of hepatic nuclear factor 4α in regulating lipid metabolism in the liver. As defects in hepatic nuclear factor 4α causes MODY 1 type diabetes (see Malecki and Giuffrida et al.) this suggest a multiorgan connection between diabetes and lipid metabolism.
   Google Scholar
• Hertz R, Kalderon B, Byk T et al.: Thioesterase activity and acyl-CoA/fatty acid cross-talk of hepatocyte nuclear factor 4 . J. Biol. Chem. 280(26), 24451–24461 (2005).
   Google Scholar
• Latest in a series of excellent research studies proving that fatty acid derivatives regulate hepatic nuclear factor 4α, a pivotal factor in some types of diabetes (see Malecki and Giuffrida et al.) and in lipid metabolism (see Hayhurst et al.).
   Google Scholar
• Suviolahti E, Lilja HE, Pajukanta P: Unraveling the complex genetics of familial combined hyperlipidemia. Ann. Med. 38(5), 337–351 (2006).
   Google Scholar
• Reviews the state of art in genetics of familial combined hyperlipidemia, and demonstrates the clinical and genetic complexity of heterogenous conditions.
   Google Scholar
• Malecki MT: Genetics of Type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 68(Suppl. 1) S10–S21 (2005).
   Google Scholar
• Excellent review of the status the genetics of diabetes.
   Google Scholar
• Topol EJ, Smith J, Plow EF, Wang QK: Genetic susceptibility to myocardial infarction and coronary artery disease. Hum. Mol. Genet. 15 Spec No 2, R117–R123 (2006).
   Google Scholar
• Rip J, Nierman MC, Ross CJ et al.: Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation. Arterioscler. Thromb. Vasc. Biol. 26(6), 1236–1245 (2006).
   Google Scholar
• Itabe H, Ueda M: Measurement of plasma oxidized low-density lipoprotein and its clinical implications. J. Atheroscler. Thromb. 14(1), 1–11 (2007).
   Google Scholar
• Nilsson J, Nordin FG, Schiopu A, Shah PK, Jansson B, Carlsson R: Oxidized LDL antibodies in treatment and risk assessment of atherosclerosis and associated cardiovascular disease. Curr. Pharm. Des. 13(10), 1021–1030 (2007).
   Google Scholar
• Kahn SE, Hull RL, Utzschneider KM: Mechanisms linking obesity to insulin resistance and Type 2 diabetes. Nature 444(7121), 840–846 (2006).
   Google Scholar
• Short and well written (and complex) review discussing mechanisms linking obesity and diabetes.
   Google Scholar
• Haugaard SB, Andersen O, Dela F et al.: Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic -cells. Eur. J. Endocrinol. 152(1), 103–112 (2005).
   Google Scholar
• Capeau J, Magre J, Lascols O et al.: Diseases of adipose tissue: genetic and acquired lipodystrophies. Biochem. Soc. Trans. 33(Pt 5), 1073–1077 (2005).
   Google Scholar
• Mallon PW: Antiretroviral therapy and dyslipidaemia: unlocking the code. PLoS Med. 3(3), e85 (2006).
   Google Scholar
• Hansen T, Hemmingsen RP, Wang AG et al.: Apolipoprotein D is associated with long-term outcome in patients with schizophrenia. Pharmacogenomics J. 6(2), 120–125 (2006).
   Google Scholar
• Glumer C, Jorgensen T, Borch-Johnsen K: Prevalences of diabetes and impaired glucose regulation in a Danish population: The Inter99 study. Diabetes Care 26(8), 2335–2340 (2003).
   Google Scholar
• Lander ES, Linton LM, Birren B et al.: Initial sequencing and analysis of the human genome. Nature 409(6822), 860–921 (2001).
   Google Scholar
• Marks the (near) end of the Human Genome Project and describes in vast detail the results of the project. Seminal paper in human genome research.
   Google Scholar
• Collins FS, McKusick VA: Implications of the Human Genome Project for medical science. JAMA 285(5), 540–544 (2001).
   Google Scholar
• Terwilliger JD, Hiekkalinna T: An utter refutation of the ‘Fundamental Theorem of the HapMap–. Eur. J. Hum. Genet. 14(4), 426–437 (2006).
   Google Scholar
• Summarizes the serious critique of the foundation of the assumptions behind the HapMap project. Although the arguments in the paper have been disputed it remains that studies based on the basic principles in the HapMap project hardly has produced solid results. Offers some explanations for this failure, and the should be considered gravely before embarking on large scale projects in genome wide screenings.
   Google Scholar
• Gu S, Pakstis AJ, Li H, Speed WC, Kidd JR, Kidd KK: Significant variation in haplotype block structure but conservation in tagSNP patterns among global populations. Eur. J. Hum. Genet. 15(3), 302–312 (2007).
   Google Scholar
• Latest of several papers showing the limited usefulness of the concept of haplotypes and tagSNPs. Certainly, in a clinical setting in which accurate genetic diagnosis is mandatory, the haplotype concept suffers even more.
   Google Scholar
• Pierson CR, Tomczak K, Agrawal P, Moghadaszadeh B, Beggs AH: X-linked myotubular and centronuclear myopathies. J. Neuropathol. Exp. Neurol. 64(7), 555–564 (2005).
   Google Scholar
• Gordon N: Alpers syndrome: progressive neuronal degeneration of children with liver disease. Dev. Med. Child Neurol. 48(12), 1001–1003 (2006).
   Google Scholar
• Auer-Grumbach M, Mauko B, uer- Grumbach P, Pieber TR: Molecular genetics of hereditary sensory neuropathies. Neuromolecular Med. 8(1–2), 147–158 (2006).
   Google Scholar
• Haltia M: The neuronal ceroidlipofuscinoses. J. Neuropathol. Exp. Neurol. 62(1), 1–13 (2003).
   Google Scholar
• Richard G: Molecular genetics of the ichthyoses. Am. J. Med. Genet. C Semin. Med. Genet. 131C(1), 32–44 (2004).
   Google Scholar
• Vanier MT, Millat G: Niemann-Pick disease Type C. Clin. Genet. 64(4), 269–281 (2003).
   Google Scholar
• Ozkara HA: Recent advances in the biochemistry and genetics of sphingolipidoses. Brain Dev. 26(8), 497–505 (2004).
   Google Scholar
• Aerts JM, Hollak C, Boot R, Groener A: Biochemistry of glycosphingolipid storage disorders: implications for therapeutic intervention. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 358(1433), 905–914 (2003).
   Google Scholar
• Hooper AJ, van Bockxmeer FM, Burnett JR: Monogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolism. Crit. Rev. Clin. Lab. Sci. 42(5–6), 515–545 (2005).
   Google Scholar
• Berriot-Varoqueaux N, Aggerbeck LP, Samson-Bouma M, Wetterau JR: The role of the microsomal triglygeride transfer protein in abetalipoproteinemia. Annu. Rev. Nutr. 20, 663–697 (2000).
   Google Scholar
• Schonfeld G, Lin X, Yue P: Familial hypobetalipoproteinemia: genetics and metabolism. Cell. Mol. Life Sci. 62(12), 1372–1378 (2005).
   Google Scholar
• Yuan G, Wang J, Hegele RA: Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease. CMAJ 174(8), 1124–1129 (2006).
   Google Scholar
• Villeger L, Abifadel M, Allard D et al.: The UMD-LDLR database: additions to the software and 490 new entries to the database Hum. Mutat. 20(2), 81–87 (2002).
   Google Scholar
• Whitfield AJ, Barrett PH, van Bockxmeer FM, Burnett JR: Lipid disorders and mutations in the APOB gene. Clin. Chem. 50(10), 1725–1732 (2004).
   Google Scholar
• Review of the clinical and genetic features of the important apolipoprotein B mutations.
   Google Scholar
• Maxwell KN, Breslow JL: Proprotein convertase subtilisin kexin 9: the third locus implicated in autosomal dominant hypercholesterolemia. Curr. Opin. Lipidol. 16(2), 167–172 (2005).
   Google Scholar
• Smelt AH, de Beer F: Apolipoprotein E and familial dysbetalipoproteinemia: clinical, biochemical and genetic aspects. Semin. Vasc. Med. 4(3), 249–257 (2004).
   Google Scholar
• Short review of the clinical and genetic aspects of the ubiquitous apolipoprotein E.
   Google Scholar
• Hovingh GK, de Groot E, van der SW et al.: Inherited disorders of HDL metabolism and atherosclerosis. Curr. Opin. Lipidol. 16(2), 139–145 (2005).
   Google Scholar
• Zannis VI, Chroni A, Krieger M: Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. J. Mol. Med. 84(4), 276–294 (2006).
   Google Scholar
• Das UN: Pathophysiology of metabolic syndrome X and its links to the perinatal period. Nutrition 21(6), 762–773 (2005).
   Google Scholar
• Jansen S, Lopez-Miranda J, Ordovas JM et al.: Effect of 360His mutation in apolipoprotein A-IV on plasma HDL- cholesterol response to dietary fat. J. Lipid Res. 38(10), 1995–2002 (1997).
   Google Scholar
• Wong WM, Gerry AB, Putt W et al.: Common variants of apolipoprotein A-IV differ in their ability to inhibit low density lipoprotein oxidation. Atherosclerosis 192(2), 266–274 (2006).
   Google Scholar
• Jakel H, Nowak M, Helleboid-Chapman A, Fruchart-Najib J, Fruchart JC: Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins? Ann. Med. 38(1), 2–10 (2006).
   Google Scholar
• Lam CW, Yuen YP, Cheng WF et al.: Missense mutation Leu72Pro located on the carboxyl terminal amphipathic helix of apolipoprotein C-II causes familial chylomicronemia syndrome Clin. Chim. Acta 364(1–2), 256–259 (2006).
   Google Scholar
• van Dijk KW, Rensen PC, Voshol PJ, Havekes LM: The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism? Curr. Opin. Lipidol. 15(3), 239–246 (2004).
   Google Scholar